Rodent genetic models of Huntington disease

被引:116
|
作者
Heng, Mary Y. [1 ,2 ]
Detloff, Peter J. [3 ]
Albin, Roger L. [1 ,2 ,4 ]
机构
[1] Univ Michigan, Grad Program Neurosci, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
[3] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 36294 USA
[4] VAAAHS, Ctr Geriatr Res Educ & Clin, Ann Arbor, MI 48105 USA
关键词
polyglutamine; mouse; striatum;
D O I
10.1016/j.nbd.2008.06.005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington disease (HD) is a dominantly inherited human neurodegenerative disorder characterized by motor deficits, cognitive impairment, and psychiatric symptoms leading to inexorable decline and death. Since the identification of the huntingtin gene and the characteristic expanded CAG repeat/polyglutamine mutation, multiple murine genetic models and one rat genetic model have been generated. These models fall into two general categories: transgenic models with ectopic expression of the characteristic expanded CAG codon mutation, and knock-in models with expression of mutant huntingtin under control of endogenous regulatory elements. Rodent genetic models are valuable tools for studying mechanisms of pathogenesis in HD and for preclinical evaluation of possible therapies. In this mini-review, we provide a concise comparative summary of rodent genetic models of HD. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [1] Genetic Rodent Models of Huntington Disease
    Stricker-Shaver, J.
    Novati, A.
    Yu-Taeger, L.
    Nguyen, H. P.
    POLYGLUTAMINE DISORDERS, 2018, 1049 : 29 - 57
  • [2] Large Genetic Animal Models of Huntington's Disease
    Morton, A. Jennifer
    Howland, David S.
    JOURNAL OF HUNTINGTONS DISEASE, 2013, 2 (01) : 3 - 19
  • [3] Huntington's Disease - New Perspectives Based on Neuroendocrine Changes in Rodent Models
    Petersen, Asa
    Hult, Sofia
    Kirik, Deniz
    NEURODEGENERATIVE DISEASES, 2009, 6 (04) : 154 - 164
  • [4] CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington's disease
    Choi, Yun-Sik
    Lee, Boyoung
    Cho, Hee-Yeon
    Reyes, Iza B.
    Pu, Xin-An
    Saido, Takaomi C.
    Hoyt, Kari R.
    Obrietan, Karl
    NEUROBIOLOGY OF DISEASE, 2009, 36 (02) : 259 - 268
  • [5] Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms
    Cepeda, Carlos
    Cummings, Damian M.
    Andre, Veronique M.
    Holley, Sandra M.
    Levine, Michael S.
    ASN NEURO, 2010, 2 (02):
  • [6] Mitochondria and Huntington's Disease Pathogenesis Insight from Genetic and Chemical Models
    Browne, Susan E.
    MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS, 2008, 1147 : 358 - 382
  • [7] Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models
    Cepeda, Carlos
    Levine, Michael S.
    NEUROSCIENTIST, 2022, 28 (01) : 20 - 40
  • [8] Transgenic Mouse Models of Parkinson's Disease and Huntington's Disease
    Skaper, Stephen D.
    Giusti, Pietro
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (04) : 455 - 470
  • [9] Neuroprotection by encapsulated choroid plexus in a rodent model of Huntington's disease
    Borlongan, CV
    Skinner, SJM
    Geaney, M
    Vasconcellos, AV
    Elliott, RB
    Emerich, DF
    NEUROREPORT, 2004, 15 (16) : 2521 - 2525
  • [10] Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease
    Cummings, Damian M.
    Cepeda, Carlos
    Levine, Michael S.
    ASN NEURO, 2010, 2 (03): : 147 - 156